Table 1. Comparison of demographics and baseline variables and outcomes in each group.
| DME (mean±SD) | Control (mean±SD) | P-value | |
|---|---|---|---|
| Age (years) | 61.03±7.13 | 56.79±7.21 | 0.019 |
| Gender (male/female) | 12/21 | 13/21 | 0.346 |
| Hemoglobin A1c (%) | 7.3±1.7 | 6.3±1.5 | <0.001 |
| DME duration (months) | 16.2 | NA | NA |
| Lens Status (n) | |||
| Phakic | 25 | 34 | NA |
| Pseudophakic | 9 | — | |
| BCVA (logMAR) | 0.72±0.57 | 0.00 | <0.001 |
| SE (D) | 0.42±0.79 | 0.32±0.52 | 0.36 |
| AL (mm) | 23.25±0.64 | 23.41± 0.75 | 0.350 |
| CFT (μm) | 414±148 | 212±20 | <0.001 |
| IOP (mm Hg) | 18.41±3.50 | 17.19±2.14 | 0.091 |
| OPA | 2.58±0.96 | 3.52±1.03 | <0.001 |
Abbreviations: AL, axial length; BCVA, best-corrected visual acuity; CFT, central foveal thickness; D, diopters; DME, diabetic macular edema; IOP, intraocular pressure; n, number; NA, not applicable; OPA, ocular pulse amplitude; SE, spherical equivalent.
P<0.05 indicates statistically significance.